title: Type 1 cryoglobulinemia: response to thalidomide and lenalidomide.
authors: Ohio University of Osteopathic Medicine, Cleveland, OH, USA.
authors: Cassandra
authors: C
authors: Calabrese
authors: Beth
authors: B
authors: Faiman
authors: David
authors: D
authors: Martin
authors: Frederic
authors: F
authors: Reu
authors: Leonard H
authors: LH
authors: Calabrese
mesh_terms: D003449:Cryoglobulinemia / Q000145:classification* / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide; D000077269:Lenalidomide